Home/ Stocks/ PRQR

ProQR Therapeutics N.V. Ordinary Shares

PRQR XNAS

$1.58 +0.01 (+0.63%) ▲ 15-min delayed

Open

$1.57

High

$1.63

Low

$1.51

Volume

664.0K

Market Cap

$166.47M

About ProQR Therapeutics N.V. Ordinary Shares

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Employees: 187 Website →

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026

Calendar →

Related Market News

No specific coverage for PRQR yet. Check out our latest market news or earnings calendar.

Get PRQR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on ProQR Therapeutics N.V. Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.